Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Director departure
Appointed director
DYADIC INTERNATIONAL INC (DYAI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
10/06/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
08/09/2023 8-K Quarterly results
Docs: "Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress"
05/10/2023 8-K Quarterly results
Docs: "Dyadic Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress"
03/29/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
03/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
02/22/2023 8-K Quarterly results
01/24/2023 8-K Quarterly results
01/23/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "SECURITIES PURCHASE AGREEMENT by and among M A R A V A I L IF E S C I E N C E S H O L D I N G S, I N C., ALPHAZYME, LLC, SELLERS, BENOIT CAPITAL PARTNERS LLC, as Sellers' Representative, and CHRIS BENOIT, as Guarantor",
" "
01/04/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " ",
" "
11/10/2022 8-K Quarterly results
Docs: "Dyadic Reports Third Quarter 2022 Financial Results and Highlights Recent Company Developments"
10/27/2022 8-K Quarterly results
09/13/2022 8-K Investor presentation
Docs: " ",
" "
08/10/2022 8-K Quarterly results
06/13/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
04/26/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/13/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
03/29/2022 8-K Quarterly results
Docs: "DYADIC REPORTS 2021 YEAR END RESULTS AND RECENT COMPANY PROGRESS"
03/18/2022 8-K Termination of a Material Definitive Agreement  Interactive Data
02/10/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
12/17/2021 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "RESEARCH, LICENSE, AND COLLABORATION AGREEMENT between DYADIC INTERNATIONAL INC. and JANSSEN BIOTECH, INC. Dated as of [●]",
" "
12/02/2021 8-K Quarterly results
11/10/2021 8-K Quarterly results
Docs: "DYADIC INTERNATIONAL, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenues: Research and development revenue $ 692,929 $ 416,361 $ 2,090,541 $ 1,256,004 Costs and expenses: Costs of research and development revenue 392,544 266,929 1,612,810 1,169,351 Provision for contract losses — 112,433 — 187,388 Research and development 1,901,548 986,054 5,918,888 2,857,670 General and administrative 1,692,837 1,643,493 4,994,458 4,772,117 Foreign currency exchange loss , net 30,002 76,080 26,317 Total costs and expenses 4,016,931 2,992,669 12,602,236 9,012,843 Loss from operations Other income: Interest income 3,202 76,809 49,772 391,779 Other income 1,605,532 — 1,605,532 — Total other income 1,608,7..."
11/09/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: " ",
" "
10/18/2021 8-K Regulation FD Disclosure  Interactive Data
08/12/2021 8-K Quarterly results
Docs: "DYADIC INTERNATIONAL, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS Three Months Ended June 30, Six Months Ended June 30, 2021 2020 2021 2020 Revenues: Research and development revenue $ 937,092 $ 524,271 $ 1,397,612 $ 839,643 Costs and expenses: Costs of research and development revenue 829,504 624,240 1,220,266 902,422 Provision for contract losses — 74,955 — 74,955 Research and development 2,209,242 1,116,163 4,017,340 1,871,616 General and administrative 1,747,614 1,475,232 3,301,621 3,128,624 Foreign currency exchange loss , net 17,806 31,690 46,078 42,557 Total costs and expenses 4,804,166 3,322,280 8,585,305 6,020,174 Loss from operations Interest income 20,900 146,587 46,570 314,970 Net loss $ $ $ $ Basic and diluted net loss per common share $ $ $ $ Basic and dilut..."
08/11/2021 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "TERM SHEET FOR INTELLECTUAL PROPERTY LICENSE AGREEMENT This Term Sheet outlines the terms and conditions of an Intellectual Property License Agreement pursuant to which Dyadic International , Inc. would exclusively license certain patents and patent applications, know-how, trade secrets, and other intellectual property to Sorrento Therapeutics, Inc. . The terms and conditions set forth in this Term Sheet are legally binding upon the parties hereto. Licensor: Dyadic International , Inc. Licensee: Sorrento Therapeutics, Inc. Licensed IP: All Licensed Patents, and all Licensed Know-How. Licensed Patents All patents and applications owned or controlled by Licensor as of the effective date of the License Agreement or at any time during the term of the License Agreement that are necessary or use...",
" "
07/27/2021 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: " ",
" ",
" "
07/27/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: " "
06/14/2021 8-K Quarterly results
06/03/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy